quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:05:31·931d
SECFiling
Yumanity Therapeutics Inc. logo

Yumanity Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits

YMTX· Yumanity Therapeutics Inc.
Health Care
Original source

Companies

  • YMTX
    Yumanity Therapeutics Inc.
    Health Care

Related

  • 13D/G799d
    SEC Form SC 13G filed by Yumanity Therapeutics Inc.
  • 13D/G801d
    SEC Form SC 13D/A filed by Yumanity Therapeutics Inc. (Amendment)
  • 13D/G801d
    SEC Form SC 13G/A filed by Yumanity Therapeutics Inc. (Amendment)
  • SEC827d
    Yumanity Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC839d
    Yumanity Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC860d
    Yumanity Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
  • INSIDER869d
    Bartoszek Raymond J. bought $9,950 worth of shares (2,250 units at $4.42), increasing direct ownership by 15% to 17,206 units (SEC Form 4)
  • INSIDER875d
    Philips Craig W. bought $9,812 worth of shares (3,000 units at $3.27), increasing direct ownership by 5% to 60,811 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022